AI Buyer Insights:

Michelin, an e2open customer evaluated Oracle Transportation Management

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

List of Remco Software Ncrunch Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight Insight Source
HealthEquity Professional Services 3170 $1.0B United States Remco Software Remco Software Ncrunch Test Automation Platform 2024 n/a In 2024 HealthEquity deployed Remco Software Ncrunch within its Test Automation Platform stack for United States engineering teams. Internal tooling inventories and job postings list Remco Software Ncrunch among developer code productivity and testing tools used by software engineers, establishing the year and application association for the implementation. Remco Software Ncrunch is configured as a Visual Studio continuous test runner for .NET, enabling continuous .NET test automation directly in developer workflows. The implementation emphasizes in-IDE test execution, automated background test runs, and live feedback on failing tests and test coverage, aligning with standard Test Automation Platform capabilities for unit and component test orchestration. Operational coverage is concentrated on HealthEquity US engineering teams and impacts software engineering and test engineering functions, where the tool is embedded in developer toolchains and code review workflows. The rollout pattern inferred from job descriptions suggests team level adoption and incorporation into developer onboarding to standardize .NET test practices across squads. HealthEquity uses Remco Software Ncrunch for continuous .NET test automation to accelerate development and improve code quality as stated in engineering hiring materials. The narrative focuses on tooling level automation and developer centric test orchestration within the Test Automation Platform.
ION Group Professional Services 13000 $900M United Kingdom Remco Software Remco Software Ncrunch Test Automation Platform 2024 n/a In 2024, ION Group began using Remco Software Ncrunch within its Test Automation Platform footprint for .NET development across its India engineering organization, with job postings explicitly listing NCrunch as a preferred skill for .NET roles in trading and financial software engineering. The presence of Remco Software Ncrunch in hiring requirements signals active use by developer teams building and maintaining trading systems, and establishes the application name and Test Automation Platform category within the company’s tooling inventory. Implementation scope centers on in-IDE continuous test automation, with Remco Software Ncrunch used as a Visual Studio continuous test runner for .NET projects. Configuration patterns inferred from role descriptions indicate developer-centric deployment, where NCrunch executes tests continuously during code edit cycles to provide rapid feedback, exercise unit and integration tests, and surface regressions inside Visual Studio. Integration and operational coverage are concentrated in ION Group India’s trading and financial software engineering squads, with the primary explicit integration being Visual Studio as the runtime and user interface for continuous test execution. The relationship is therefore ION Group Remco Software Ncrunch Test Automation Platform supporting finance and trading software engineering workflows, embedded at the developer workstation and applied to .NET codebases used in trading systems. Governance signals derive from recruiting language that treats NCrunch proficiency as a standard expectation, implying enforced developer toolchain consistency and role-level skill requirements rather than ad hoc usage. This hiring-driven governance suggests rollout through team-level developer standards and inclusion in onboarding for India-based engineering staff, aligning the Test Automation Platform with existing coding and quality assurance practices.
Trustpilot USA Professional Services 250 $30M United States Remco Software Remco Software Ncrunch Test Automation Platform 2012 n/a In 2012, Trustpilot USA implemented Remco Software Ncrunch as part of a core architecture overhaul, deploying Remco Software Ncrunch within its software development toolchain. Remco Software Ncrunch, classified as a Test Automation Platform, was cited in the case study tool list as supporting continuous testing in the .NET stack, aligned with an initiative focused on scalability and faster delivery. The implementation centered on using NCrunch as a Visual Studio continuous test runner, configured to execute unit and integration test suites in the developer workflow to shorten feedback loops. Configuration work emphasized continuous testing capabilities native to the Test Automation Platform category, including automated test execution during edit-build cycles and in-memory test instrumentation to surface regressions during development. Operational coverage included Denmark-based development teams engaged in the architecture overhaul, indicating the rollout targeted developer workstations and team-level CI-adjacent workflows that support the broader software development function. Integration scope described in the case material connects Remco Software Ncrunch to standard .NET testing frameworks and Visual Studio IDE workflows, and governance focused on embedding continuous test practices into developer processes to support scalability and faster delivery.
Showing 1 to 3 of 3 entries

Buyer Intent: Companies Evaluating Remco Software Ncrunch

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Remco Software Ncrunch. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Remco Software Ncrunch Coverage

Remco Software Ncrunch is a Test Automation Platform solution from Remco Software.

Companies worldwide use Remco Software Ncrunch, from small firms to large enterprises across 21+ industries.

Organizations such as HealthEquity, ION Group and Trustpilot USA are recorded users of Remco Software Ncrunch for Test Automation Platform.

Companies using Remco Software Ncrunch are most concentrated in Professional Services, with adoption spanning over 21 industries.

Companies using Remco Software Ncrunch are most concentrated in United States and United Kingdom, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Remco Software Ncrunch across Americas, EMEA, and APAC.

Companies using Remco Software Ncrunch range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 33.33%, large organizations with 1,001-10,000 employees - 33.33%, and global enterprises with 10,000+ employees - 33.33%.

Customers of Remco Software Ncrunch include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Remco Software Ncrunch customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Test Automation Platform.